Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer.

Hilbers FS, Boekel NB, van den Broek AJ, van Hien R, Cornelissen S, Aleman BM, van 't Veer LJ, van Leeuwen FE, Schmidt MK.

Radiother Oncol. 2012 Jan;102(1):115-21. doi: 10.1016/j.radonc.2011.10.017. Epub 2011 Nov 17.

PMID:
22100658
[PubMed - indexed for MEDLINE]
2.

Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly.

Crainich P, Jenny NS, Tang Z, Arnold AM, Kuller LH, Manolio T, Sharrett AR, Tracy RP.

J Thromb Haemost. 2003 Aug;1(8):1799-804.

PMID:
12911596
[PubMed - indexed for MEDLINE]
3.

Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.

Roest M, van der Schouw YT, Banga JD, Tempelman MJ, de Groot PG, Sixma JJ, Grobbee DE.

Circulation. 2000 Jan 4-11;101(1):67-70.

PMID:
10618306
[PubMed - indexed for MEDLINE]
Free Article
4.

Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.

Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.

Thromb Res. 2006;117(5):487-92.

PMID:
15907980
[PubMed - indexed for MEDLINE]
5.

Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.

Terrazzino S, La Mattina P, Gambaro G, Masini L, Franco P, Canonico PL, Genazzani AA, Krengli M.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):504-11. doi: 10.1016/j.ijrobp.2011.06.2012. Epub 2011 Nov 11.

PMID:
22079734
[PubMed - indexed for MEDLINE]
6.

Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.

Heijmans BT, Westendorp RG, Knook DL, Kluft C, Slagboom PE.

J Am Coll Cardiol. 1999 Oct;34(4):1176-83.

PMID:
10520809
[PubMed - indexed for MEDLINE]
Free Article
7.

Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE.

J Natl Cancer Inst. 2007 Mar 7;99(5):365-75.

PMID:
17341728
[PubMed - indexed for MEDLINE]
Free Article
8.

Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.

Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.

Prostate. 2007 Feb 1;67(2):172-7.

PMID:
17044080
[PubMed - indexed for MEDLINE]
9.

Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.

Eroglu A, Ulu A, Cam R, Akar N.

J BUON. 2006 Oct-Dec;11(4):481-4.

PMID:
17309181
[PubMed - indexed for MEDLINE]
10.

4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.

Hoekstra T, Geleijnse JM, Kluft C, Giltay EJ, Kok FJ, Schouten EG.

Stroke. 2003 Dec;34(12):2822-8. Epub 2003 Nov 6.

PMID:
14605330
[PubMed - indexed for MEDLINE]
Free Article
11.

Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.

Björck HM, Eriksson P, Alehagen U, De Basso R, Ljungberg LU, Persson K, Dahlström U, Länne T.

Am J Hypertens. 2011 Jul;24(7):802-8. doi: 10.1038/ajh.2011.63. Epub 2011 Apr 14.

PMID:
21490692
[PubMed - indexed for MEDLINE]
12.

Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

Ziv E, Cauley J, Morin PA, Saiz R, Browner WS.

JAMA. 2001 Jun 13;285(22):2859-63. Erratum in: JAMA 2001 Dec 26;286(24):3081.

PMID:
11401606
[PubMed - indexed for MEDLINE]
13.

The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene.

Lazo-Langner A, Knoll GA, Wells PS, Carson N, Rodger MA.

Blood. 2006 Dec 15;108(13):4052-8. Epub 2006 Aug 24.

PMID:
16931622
[PubMed - indexed for MEDLINE]
Free Article
14.

Prognostic value of the PAI-1 4G/5G polymorphism in invasive ductal carcinoma of the breast.

Yagmurdur MC, Atac FB, Tutar NU, Verdi H, Isiklar I, Ozdemir BH, Ozbek N, Karakayali H, Haberal M.

Int Surg. 2008 May-Jun;93(3):163-8.

PMID:
18828272
[PubMed - indexed for MEDLINE]
15.

PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.

Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.

Obesity (Silver Spring). 2006 May;14(5):753-8.

PMID:
16855181
[PubMed - indexed for MEDLINE]
16.

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.

Su CK, Yeh KT, Yeh CB, Wang PH, Ho ES, Chou MC, Liu KC, Yang SF, Yi YC.

J Surg Oncol. 2011 Dec;104(7):755-9. doi: 10.1002/jso.22035. Epub 2011 Jul 14.

PMID:
21761413
[PubMed - indexed for MEDLINE]
17.

Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients.

Chow KM, Szeto CC, Szeto CY, Poon P, Lai FM, Li PK.

Transplantation. 2002 Dec 27;74(12):1791-4.

PMID:
12499900
[PubMed - indexed for MEDLINE]
18.

Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival.

Zhang X, Shu XO, Cai Q, Ruan Z, Gao YT, Zheng W.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6037-42.

PMID:
17062678
[PubMed - indexed for MEDLINE]
Free Article
19.

The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.

Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.

Thromb Haemost. 1998 May;79(5):975-9.

PMID:
9609232
[PubMed - indexed for MEDLINE]
20.

Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume.

Borger JH, Hooning MJ, Boersma LJ, Snijders-Keilholz A, Aleman BM, Lintzen E, van Brussel S, van der Toorn PP, Alwhouhayb M, van Leeuwen FE.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1131-8. Epub 2007 Jul 2.

PMID:
17606332
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk